Skip to content

A research about efficacy of sulfasalazine in the treatment of oral lichen planus.

A case report about efficacy of sulfasalazine in the treatment of oral lichen planus.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0000665
Enrollment
90
Registered
2013-02-07
Start date
2011-02-22
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : sulfasalazine(???), 30mg, 200mg, 500mg/5ml(water), tid for 3 minutes, for 4 weeks, topical application on lesion. After application, the obsevation period is 4 weeks.

Sponsors

Pusan National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the patients with oral lichen planus in Pusan National University Dental Hospital, who resistant to corticosteroid therapy.

Exclusion criteria

Exclusion criteria: the patients with oral lichen planus in Pusan National University Dental Hospital, who resistant to corticosteroid therapy. including other GI tract trouble or dermatologic problems

Design outcomes

Primary

MeasureTime frame
measurement size of lesion

Secondary

MeasureTime frame
visual analogue scale (VAS)

Countries

Korea, Republic of

Contacts

Public ContactSung hee Jeong

Pusan National University Dental Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026